Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
The Walt Disney Company Fiscal Q2 2026 Earnings Call - Disney+ revenue accelerates, platform set as company's digital centerpiece
Josh D’Amaro used his first earnings call as CEO to signal continuity and focus, not wholesale change. Disney reported organic top-line momentum, with consolidated revenue and total segment operating ...
- CEO transition framed as continuity, not overhaul, with Josh D’Amaro promising disciplined execution against existing plans while preparing the company for a technology-driven, connected next phase.
- Consolidated revenue rose 7% year over year, total segment operating income rose 4%, and the quarter outperformed company guidance driven largely by stronger revenue.
- Streaming momentum: Disney+ entertainment SVOD revenue growth accelerated sequentially from 11% in Q1 to 13% in Q2, driven by both price increases and subscriber volume.
- +13 more takeaways
Mistras Group, Inc. Q1 2026 Earnings Call - Margin-first strategy: aerospace and infrastructure lift profits while selective oil and gas exits trim revenue
Mistras delivered a tidy quarter where quality of revenue mattered more than quantity. Revenue grew about 4.6% as Aerospace & Defense and Infrastructure drove the top line, while management intentiona...
- Total revenue grew 4.6% year-over-year, driven by strength in strategic growth markets outside oil and gas.
- Oil and gas revenue declined $11.1 million, or 11.5%, driven by industry-wide deferments and a purposeful exit from low-margin run-and-maintain contracts.
- About two thirds of the oil and gas decline is attributable to management decisions to walk away from low-margin work, prioritizing margin over volume.
- +16 more takeaways
Bio-Techne Corporation Q3 FY2026 Earnings Call - Spatial and GMP strength offset by biotech timing and Fast Track order delays
Bio-Techne delivered a mixed quarter: clear wins in spatial biology, proteomic instruments and GMP proteins were offset by timing effects tied to two Fast Track cell therapy customers and a shifted OE...
- Q3 revenue $311.4 million, down 2% on both an organic and reported basis.
- Adjusted EPS $0.53, GAAP EPS $0.32 for the quarter.
- Management cites order timing from two cell therapy customers with FDA Fast Track designation plus a large OEM commercial supply order as a combined ~400 basis point headwind; CFO quantified this as ~3% from cell therapy timing and ~1% OEM timing.
- +13 more takeaways
Clean Harbors Q1 2026 Earnings Call - Raised Full-Year Adjusted EBITDA as SKSS Base Oil Rally and ES Momentum Drive Upside
Clean Harbors started 2026 stronger than expected, reporting Q1 revenue of $1.46 billion and adjusted EBITDA of $248 million, a 6% y/y increase and a 60 basis point margin expansion. Management raised...
- Q1 results beat expectations, revenue $1.46 billion, adjusted EBITDA $248 million, adjusted EBITDA margin 17%, up 60 basis points y/y.
- Management raised 2026 adjusted EBITDA guidance to $1.24 billion-$1.30 billion, midpoint $1.27 billion, an increase of $40 million from prior guidance.
- SKSS outperformance is the primary driver of the guide raise, management now expects SKSS to deliver about $165 million of adjusted EBITDA in 2026, roughly 20% above 2025.
- +14 more takeaways
Owens Corning Q1 2026 Earnings Call - Margins Hold Up Even as Demand and Inflation Bite
Owens Corning reported a sturdy quarter amid softer end markets, delivering $2.3 billion in revenue and $369 million of adjusted EBITDA, a 16% margin, underscoring the leverage from recent portfolio m...
- Q1 results: $2.3 billion revenue, $369 million adjusted EBITDA, 16% adjusted EBITDA margin, adjusted EPS $1.22.
- Free cash flow was a net outflow of $387 million in Q1, driven by seasonal working capital and elevated capital additions of $210 million.
- Balance sheet and liquidity: return on capital 10% for trailing 12 months, debt to EBITDA 2.5x, liquidity $1.8 billion ($272 million cash, $1.5 billion available bank facility).
- +12 more takeaways
Corteva Agriscience Q1 2026 Earnings Call - Strong Q1 Performance Reaffirms 2026 Guidance and Advances Separation
Corteva opened the year with a clean, loud beat. Q1 delivered 21% operating EBITDA growth, about 240 basis points of margin expansion, and organic sales up 7%, driven by seed strength in North America...
- Q1 operating EBITDA rose 21% year-over-year, with operating EBITDA above $1.4 billion and margin expanding roughly 240 basis points to over 29%.
- Organic sales grew 7% in Q1, with Seed up 9% and Crop Protection up 4%.
- Seed price mix improved 3% and volumes were up 6%, driven by North America timing and strong demand for newer hybrids and varieties.
- +12 more takeaways
Icahn Enterprises L.P. Q1 2026 Earnings Call - NAV Up on CVI Gains, Refining Hedges Drag Results
Leadership changed midstream, but the balance sheet did not. New CEO Ted Papapostolou and incoming CFO Robert Flint inherit a portfolio that posted a $201 million NAV gain for the quarter, driven larg...
- Management transition: Ted Papapostolou named CEO, Robert Flint elevated to CFO, Andrew Teno stepped down; Carl Icahn remains central to strategy and oversight.
- Indicative NAV rose $201 million versus year-end, primarily driven by a $605 million increase in the long position in CVI.
- CVI was the quarter's largest positive driver, management cited geopolitical volatility as creating attractive opportunities, and CVI announced a $0.10 dividend.
- +11 more takeaways
Jackson Financial Q1 2026 Earnings Call - Spread-based and RILA momentum supports $1.2B free capital target and stronger returns
Jackson opened 2026 with a quarter that underlines a deliberate pivot: spread-based products and RILAs are now the growth engine, and management is betting those streams will fund capital returns and ...
- Management calls 2026 off to a strong start, citing execution through market volatility and progress toward 2026 targets.
- Total adjusted capital ended Q1 at $5.5 billion, up nearly 5% year-over-year, with an estimated RBC ratio around 554% and an RBC risk appetite of 425%.
- Free capital generation was $271 million in Q1, with a full-year target of $1.2 billion assuming a 5% equity market return and interest rates tracking the forward curve.
- +13 more takeaways
NRG Energy, Inc. First Quarter 2026 Earnings Call - Reaffirmed Guidance While Doubling Down on Contracted Gen and Large-Load Opportunity
NRG reported a soft Q1 driven by unusually mild Texas weather and Winter Storm Fern-related eastern supply costs, yet management reaffirmed full-year 2026 guidance and reiterated capital discipline fo...
- Robert Gaudette is now CEO, emphasizing disciplined capital allocation, operational execution, and converting large-load opportunities into long-duration cash flows.
- Company reaffirmed full-year 2026 financial guidance despite a weak first quarter driven by mild weather in Texas and higher eastern supply costs during Winter Storm Fern.
- Q1 2026 results: adjusted EBITDA $1.08 billion, adjusted net income $308 million, adjusted EPS $1.49; adjusted EBITDA down $46 million YoY, partly due to a very strong Q1 2025 comp.
- +15 more takeaways
Hut 8 Mining Corp Q1 2026 Earnings Call - Beacon Point Phase 1 Commercialized with $9.8B 15-Year Investment Grade Lease
Hut 8 used Q1 to prove a pivot. Management sold non-core assets, spun out the volatile Bitcoin arm, rebuilt the balance sheet, and closed two program-defining transactions: commercialization of Beacon...
- Beacon Point phase 1 commercialized: 352 MW IT capacity (500 MW utility) under a 15-year triple-net lease to an investment-grade counterparty, $9.8 billion base contract value with a 3% annual escalator and three 5-year renewal options raising potential contract value above $25 billion.
- Beacon Point redesign boosted IT capacity from 224 MW to 352 MW within the same land and utility footprint, adding about $3.6 billion in base contract value, with NVIDIA as technology partner on density and architecture.
- Riverbend financed with a first-of-its-kind $3.25 billion senior secured bond: 16.5-year fully amortizing tenor, ~6.192% coupon, BBB- ratings from S&P and Fitch, non-callable, 95% loan to cost, and non-recourse to the parent.
- +11 more takeaways